|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lymphoma | |||||
| Ovarian Cancer | |||||
| Sarcoma | |||||
| Small Intestine Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Duodenal Neoplasms | |||||
| Ileal Neoplasms | |||||
| Intestinal Neoplasms | |||||
| Jejunal Neoplasms | |||||
| Ovarian Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Adnexal Diseases | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Duodenal Diseases | |||||
| Endocrine Gland Neoplasms | |||||
| Endocrine System Diseases | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Genital Diseases, Female | |||||
| Genital Neoplasms, Female | |||||
| Gonadal Disorders | |||||
| Ileal Diseases | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Intestinal Diseases | |||||
| Jejunal Diseases | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Connective and Soft Tissue | |||||
| Ovarian Diseases | |||||
| Urogenital Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| tanespimycin | |||||
| 5 | Sponsors listed in this trial | ||||
| UPMC Cancer Centers | |||||
| National Cancer Institute (NCI) | |||||